SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-441265
Filing Date
2014-12-12
Accepted
2014-12-12 16:17:35
Documents
3
Period of Report
2014-12-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d835359d8k.htm 8-K 18587
2 EX-99.1 d835359dex991.htm EX-99.1 7723
3 GRAPHIC g835359ex99_1logo.jpg GRAPHIC 8116
  Complete submission text file 0001193125-14-441265.txt   38882
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35945 | Film No.: 141283839
SIC: 2834 Pharmaceutical Preparations